Heartflow (NASDAQ:HTFL) CFO Sells $379,783.69 in Stock

Key Points

• CFO Vikram Verghese sold 7,579 Heartflow shares at an average price of $50.11, generating $379,783.69. The transaction was made under a pre-arranged Rule 10b5-1 plan, leaving him with 171,949 shares.
• Verghese has made several additional sales in September, including 16,766 shares on September 18 and 29,714 shares on September 11, indicating substantial recent insider selling.
• Heartflow shares traded at $50.75, near their 52-week high of $52.22. The company recently reported revenue growth of 47.7% year over year and better-than-expected quarterly EPS, while analysts maintain a “Moderate Buy” consensus rating with an average price target of $44.88.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CFO Vikram Verghese sold 7,579 shares of Heartflow stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $50.11, for a total transaction of $379,783.69. Following the completion of the transaction, the chief financial officer owned 171,949 shares in the company, valued at approximately $8,616,364.39. This trade represents a 4.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

• On Friday, September 18th, Vikram Verghese sold 16,766 shares of Heartflow stock. The stock was sold at an average price of $50.75, for a total value of $850,874.50.
• On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The stock was sold at an average price of $50.01, for a total value of $33,406.68.
• On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The shares were sold at an average price of $50.24, for a total value of $230,752.32.
• On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The shares were sold at an average price of $50.06, for a total value of $1,487,482.84.
• On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The stock was sold at an average price of $50.03, for a total value of $332,199.20.
• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The shares were sold at an average price of $49.69, for a total transaction of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The stock was sold at an average price of $50.60, for a total transaction of $297,325.60.

Heartflow Stock Performance

Shares of Heartflow stock traded up $1.18 during trading on Friday, hitting $50.75. The stock had a trading volume of 6,606,910 shares, compared to its average volume of 1,824,326. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $52.22. The stock has a 50 day simple moving average of $37.75 and a 200 day simple moving average of $31.70.

Heartflow (NASDAQ:HTFL - Get Free Report) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million during the quarter. The business's revenue was up 47.7% on a year-over-year basis. As a group, equities research analysts predict that Heartflow, Inc. will post -0.75 EPS for the current year.

Hedge Funds Weigh In On Heartflow

A number of hedge funds have recently modified their holdings of HTFL. XXEC Inc. purchased a new position in Heartflow in the second quarter valued at about $2,524,764,000. BlackRock Inc. purchased a new stake in shares of Heartflow during the 2nd quarter worth about $152,502,000. Bamco Inc. NY purchased a new stake in shares of Heartflow during the 2nd quarter worth about $94,625,000. Jupiter Topco LLC acquired a new stake in shares of Heartflow during the 2nd quarter valued at about $70,983,000. Finally, Janus Henderson Group PLC grew its stake in shares of Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company's stock valued at $53,063,000 after buying an additional 1,315,416 shares in the last quarter.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on HTFL. Stifel Nicolaus lifted their price target on Heartflow from $40.00 to $45.00 and gave the company a "buy" rating in a report on Friday, August 14th. Weiss Ratings raised Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, August 7th. Wells Fargo & Company raised their price objective on Heartflow from $37.00 to $39.00 and gave the stock an "overweight" rating in a research report on Friday, August 14th. Benchmark reiterated a "buy" rating on shares of Heartflow in a report on Friday, August 14th. Finally, Morgan Stanley increased their price target on shares of Heartflow from $35.00 to $40.00 and gave the stock an "equal weight" rating in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Heartflow presently has an average rating of "Moderate Buy" and an average price target of $44.88.

About Heartflow

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient's coronary arteries.

The company's primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.